Erwan Mortier, n/a

Université de Nantes, CNRS, Inserm, CRCINA, F-44000 Nantes, France; LabEx IGO “Immunotherapy, Graft, Oncology”, Nantes, France; Université de Nantes, Inserm, CNRS, CHU Nantes, SFR Santé, FED 4203, Inserm UMS 016, CNRS, UMS 3556, IMPACT Platform, Nantes, France, France

Poster(s):

• Tu44 - Immunotherapy Using IL-34 for the Treatment of GvHD and Solid Organ Rejection: Strategies for its Optimisation
  Tuesday, June 21, 2022

  6:15 PM – 7:45 PM PT